Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Paraproteinemias × Erlotinib Hydrochloride × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 122 Lung Neoplasms 46 Pancreatic Neoplasms 29 Non-Squamous Non-Small Cell Lung Cancer 15 Neoplasms 15 Glioblastoma 12 Gliosarcoma 11 Breast Neoplasms 11 Adenocarcinoma of Lung 11 Brain Neoplasms 10 Neoplasm Metastasis 9 Head and Neck Neoplasms 9 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 7 Carcinoma, Squamous Cell 6 Astrocytoma 6 Adenocarcinoma, Bronchiolo-Alveolar 6 Squamous Cell Carcinoma of Head and Neck 5 Oligodendroglioma 5 Urinary Bladder Neoplasms 4 Glioma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma 4 Adenocarcinoma 4 Recurrence 3 Rectal Neoplasms 3 Ovarian Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3

Interventions

Bortezomib 3 fludarabine 2 Tacrolimus 2 Cyclophosphamide 2 ofatumumab 1 fludarabine phosphate 1 birtamimab 1 Zoledronic Acid 1 Whole-Body Irradiation 1 Vorinostat 1 Thalidomide 1 Stem Cell Transplantation 1 Plasma Exchange 1 Mycophenolic Acid 1 Melphalan 1 Lenalidomide 1 KW-2478 1 Hsp90 inhibitor KU757 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Denosumab 1 Cisplatin 1 Calcium Dobesilate 1 Busulfan 1 Alemtuzumab 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡